News Daily News Later CVD Risk From Hypertension in Pregnancy Vastly Underestimated L.A. McKeown May 05, 2020
News Daily News Alirocumab ‘Modestly’ Cost-effective at Lower List Price: ODYSSEY OUTCOMES Michael O'Riordan May 04, 2020
News As COVID-19 Spreads, US Cath Labs Ponder Fibrinolytics for STEMI Michael O'Riordan April 17, 2020
News Conference News ACC 2020 Icosapent Ethyl’s CV Benefit Closely Tied to Serum EPA Levels: REDUCE-IT Todd Neale April 02, 2020
News Conference News ACC 2020 Pooled Inclisiran Data: Safe LDL-Lowering, Plus Hints of Fewer CVD Events Michael O'Riordan April 02, 2020
News Conference News ACC 2020 Ischemia Burden Not Linked to Angina in Nonobstructive CAD: CIAO Michael O'Riordan March 31, 2020
Presentation ACC 2020 EPA Levels and Cardiovascular Outcomes in the Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial Presenter: Deepak L. Bhatt March 30, 2020
News Conference News ACC 2020 ISCHEMIA in Print: New MI Data and More Calls for Longer Follow-up Shelley Wood March 30, 2020
News Conference News ACC 2020 VOYAGER PAD: Rivaroxaban Bests Aspirin Alone for Preventing Limb and CV Events L.A. McKeown March 28, 2020
News Conference News ACC 2020 Diabetes May Boost Benefits of COMPASS Dual Antithrombotic Approach Todd Neale March 28, 2020
News Daily News COMPASS Antithrombotic Approach Works Well in Prior-PCI Patients Todd Neale March 27, 2020
News Opinion Editor's Corner A ‘Virtual’ ACC 2020? TCTMD Has You Covered, However Things Roll Out Shelley Wood March 16, 2020
News Daily News Type 2 MI Linked to More CV Deaths, Even in Younger Patients Shelley Wood March 04, 2020
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for February 2020 Shelley Wood March 02, 2020
News Daily News Meta-analysis Questions PCI vs CABG in Women With Multivessel Disease Shelley Wood February 27, 2020
News Daily News Acute MI Symptom Clustering Differs in Men and Women: VIRGO Michael O'Riordan February 21, 2020
News Daily News Stent-Related Adverse Events Continue Out to 5 Years: Meta-analysis Michael O'Riordan February 10, 2020
News Daily News Most Secondary Prevention Patients Are Eligible for Multiple Drugs Michael O'Riordan January 03, 2020